financetom
Business
financetom
/
Business
/
Fidelity National Information Q3 Adjusted Earnings, Revenue Rise; Annual Outlook Updated
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Fidelity National Information Q3 Adjusted Earnings, Revenue Rise; Annual Outlook Updated
Nov 5, 2025 4:48 AM

07:23 AM EST, 11/05/2025 (MT Newswires) -- Fidelity National Information Services ( FIS ) reported Q3 adjusted earnings Wednesday of $1.51 per diluted share, up from $1.40 a year earlier.

Analysts polled by FactSet expected $1.48.

Revenue for the quarter ended Sept. 30 was $2.72 billion, compared with $2.57 billion a year earlier.

Analysts surveyed by FactSet expected $2.66 billion.

For 2025, the company now expects adjusted EPS of $5.74 to $5.78, compared with its prior outlook of $5.72 to $5.80. Analysts polled by FactSet expect $5.75.

Revenue for the year is now estimated at between $10.6 billion and $10.63 billion, compared with its prior outlook range of $10.52 billion to $10.57 billion. Analysts polled by FactSet expect $10.53 billion.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
US could lift sanctions on more Russian oil, says Bessent
US could lift sanctions on more Russian oil, says Bessent
Mar 11, 2026
March 6 (Reuters) - Treasury Secretary Scott Bessent on Friday said the United States could remove sanctions from more Russian oil, a day after Washington issued a 30-day waiver allowing the sale of Russian crude currently stranded at sea to continue to India. We may unsanction other Russian oil, Bessent told Fox Business' Kudlow program. There are hundreds of millions...
Bridgebio Pharma Insider Sold Shares Worth $4,211,302, According to a Recent SEC Filing
Bridgebio Pharma Insider Sold Shares Worth $4,211,302, According to a Recent SEC Filing
Mar 11, 2026
05:04 PM EST, 03/06/2026 (MT Newswires) -- Andrea Ellis, Director, on March 04, 2026, sold 64,921 shares in Bridgebio Pharma ( BBIO ) for $4,211,302. Following the Form 4 filing with the SEC, Ellis has control over a total of 18,589 common shares of the company, with 18,589 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1743881/000147083126000252/xslF345X05/wk-form4_1772834274.xml ...
Offerpad Solutions Gets Non-Compliance Notice From NYSE
Offerpad Solutions Gets Non-Compliance Notice From NYSE
Mar 11, 2026
04:30 PM EST, 03/06/2026 (MT Newswires) -- Offerpad Solutions ( OPAD ) said Friday it has received a notice from the New York Stock Exchange for non-compliance with its listing rule due to a stock price deficiency. The company said it plans to consider alternatives, including a reverse stock split, subject to shareholder approval. The notice will not result in...
Savara Says FDA Letter Indicates No Advisory Committee Meeting Planned for Molbreevi Application
Savara Says FDA Letter Indicates No Advisory Committee Meeting Planned for Molbreevi Application
Mar 11, 2026
05:00 PM EST, 03/06/2026 (MT Newswires) -- Savara (SVRA) said Friday it received a letter from the US Food and Drug Administration indicating that an Advisory Committee meeting is not planned for the Biologics License Application for Molbreevi. The company said the review is ongoing with a Prescription Drug User Fee Act target action date of Aug. 22. Savara said...
Copyright 2023-2026 - www.financetom.com All Rights Reserved